Pharco and Baheya Hospitals Sign Memorandum of Understanding to Support Cancer Care

Pharco Pharmaceuticals signed a Memorandum of Understanding with Baheya Hospitals to strengthen cooperation in oncology care and support the development of healthcare services. The signing took place in the presence of Dr. Sherine Helmy, Chairman and CEO of Pharco Pharmaceuticals.

Pharco Pharmaceuticals signed a Memorandum of Understanding with Baheya Hospitals to strengthen cooperation in oncology care and support the development of healthcare services. The signing took place in the presence of Dr. Sherine Helmy, Chairman and CEO of Pharco Pharmaceuticals.

The memorandum sets out shared priorities, including supporting cancer patients throughout their care journey, raising health awareness, and promoting health education. It also covers cooperation to help develop therapeutic and healthcare services.

Continuous medical education and professional development are further areas of focus, reflecting both organisations’ commitment to supporting healthcare professionals alongside patients.

Through this collaboration, Pharco and Baheya Hospitals aim to develop joint initiatives that address these priorities and contribute to stronger healthcare services. The memorandum provides a foundation for cooperation centred on the needs of patients and the professionals responsible for their care.

— Pharco press release.